Company profile
CSL Behring Australia company profile
CSL Behring Australia offers broadest range of quality plasma-derived and recombinant therapies in industry. Their portfolio of innovative medicines includes recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and alpha-1 antitrypsin deficiency.
Business identity
- Contact email
- [email protected]
- Phone number
- +61 3 9246 5200
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 01001-05000 employees
- Revenue range
- $10M+
- Founded
- 2012-01-01
Headquarters
- Headquarters
- Broadmeadows, New South Wales, Australia
- Postal code
- 3047
- Country code
- AU
- Continent
- Oceania